Ross Kedl, PhD

Professor of Immunology & Microbiology
University of Colorado

Ross KedlDr. Kedl received his PhD in 1997 in the Department of Laboratory Medicine and Pathology at the University of Minnesota in Minneapolis. Before joining the Faculty at the University of Colorado, Dr. Kedl was at 3M Pharmaceuticals working in their small molecule immune response modifier program. In his three years there, he spearheaded efforts at developing novel vaccine adjuvants, resulting in numerous publications and patents in the area of vaccine technology. Dr. Kedl returned to the academic sector in 2004 by joining the faculty in the Integrated Department of Immunology at the University of Colorado Health Sciences Center and National Jewish Medical Research Center where he continues to pursue the discovery and development of novel and clinically applicable vaccine technology. He is also the founder of a start-up pharmaceutical company, ImmuRx Inc., which focuses on developing therapeutic vaccines against chronic infectious diseases, such as HIV and cancer.

Biography from University of Colorado.

IDIGH Calendar

<<  <  May 2019  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
    2  3  4  5
  6  7  9101112
1316171819
202123242526
27283031  

Latest IDIGH Publications

  1. Roussel, L., Landekic, M., Golizeh, M., Gavino, C., Zhong, M.-C., Chen, J., Faubert, D., Blanchet-Cohen, A., Dansereau, L., Parent, M.-A., Marin, S., Luo, J., Le, C., Ford, B. R., Langelier, M., King, I. L., Divangahi, M., Foulkes, W. D., Veillette, A. & Vinh, D. C.
    (2019)
    .
    [Loss of human ICOSLG results in combined immunodeficiency]
    .
    Medecine sciences : M/S
    ,
    vol
    .
    35
    ,
    p
    .
    625-628
    .
  2. Cheng, M. P., Stenstrom, R., Paquette, K., Stabler, S. N., Akhter, M., Davidson, A. C., Gavric, M., Lawandi, A., Jinah, R., Saeed, Z., Demir, K., Huang, K., Mahpour, A., Shamatutu, C., Caya, C., Troquet, J.-M., Clark, G., Yansouni, C. P., Sweet, D. & FABLED Investigators.
    (2019)
    .
    Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic Study
    .
    Annals of internal medicine
  3. Pearce, M. E., Jongbloed, K., Demerais, L., MacDonald, H., Christian, W. M., Sharma, R., Pick, N., Yoshida, E. M., Spittal, P. M. & Klein, M. B.
    (2019)
    .
    "Another thing to live for": Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities
    .
    The International journal on drug policy
    ,
    vol
    .
    74
    ,
    p
    .
    52-61
    .
  4. Eiwegger, T., Anagnostou, K., Arasi, S., Bégin, P., Ben-Shoshan, M., Beyer, K., Blumchen, K., Brough, H., Caubet, J.-C., Chan, E. S., Chinthrajah, S., Davis, C. M., Roches, A. D., Du Toit, G., Elizur, A., Galli, S. J., Håland, G., Hoffmann-Sommergruber, K., Kim, H., Leung, D. Y. M., Muraro, A., Nurmatov, U. B., Pajno, G. B., Sindher, S., Szepfalusi, Z., Torres, M. J., Upton, J., Worm, M. & Nadeau, K.
    (2019)
    .
    ICER report for peanut OIT comes up short
    .
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  5. Kiani, Z., Dupuy, F. P., Bruneau, J., Lebouché, B., Retière, C., Geraghty, D. E. & Bernard, N. F.
    (2019)
    .
    The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells
    .
    Journal of virology
More publications